InformedCitizen.usBeta
In committeeHealth care

National Triple-Negative Breast Cancer Day

H.Res. 182 · Resolution · Introduced March 3, 2025

This bill would express support for naming National Triple-Negative Breast Cancer Day, concerning people with this distinct form of cancer.

What stands out

Loading…

These are patterns in public records, not proof that money changed a vote. The same rules apply to every member. How we decide

At a glance

Who it affects

  • People with triple-negative breast cancer

Where it stands

In committee

Lobbying and money

No lobbying reported yet

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

What it would do

Written with AI from the official summary by Congress's research office.

How South Carolina voted

No recorded roll-call vote on this bill yet.

Groups that lobbied on it and gave to SC's members

PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.

No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

Official record

Official title, sponsor and status
Official title
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
Sponsor
Rep. Morelle, Joseph D. (D-NY)
Introduced
March 3, 2025
Cosponsors
0
Committees
House Oversight and Government Reform Committee
Latest action
March 3, 2025 · Referred to the House Committee on Oversight and Government Reform.
Congress.gov ↗
Official summary from the Congressional Research Service

This resolution expresses support for the designation of National Triple-Negative Breast Cancer Day. Triple-negative breast cancer is a distinct form of cancer that does not have the hormone and protein receptors commonly found in breast cancer.

Summary on Congress.gov ↗
Everyone who lobbied on this bill (0 groups)

No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.